PCN116 Economic Impact of First-Line (1L) Immunotherapies in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)
Abstract
Authors
G. Sarri A. Freitag P. Kazmierska B. Lin V. Pawar X. Zhang